GT Biopharma
GTBP | NASDAQ
$3.54
-$0.18 (-4.84%)
At close: Nov 16, 2026, 4:00 PM ET
$3.61
+$0.07 (+1.98%)
After-hours:
Nov 16, 2026, 6:41 PM ET
GT Biopharma Statistics
Key statistics explainedMarket Data
$5.5M
$537K
0.83
56.29K
1.55M
1300.57%
5.42%
NASDAQ
US36254L4077
Price Performance
-49.6%
-50.3%
-61.1%
-82.0%
-79.4%
-98.0%
-99.9%
-49.6%
-84.6%
-74.9%
-68.7%
Valuation
-0.03
N/A
0.00
0.00
N/A
0.10
1.54
-0.38
-0.36
-0.38
N/A
-0.03
-0.03
-0.04
-2937.8%
-262.4%
-278.9%
Financial Health
$4.96M
$0
$4.96M
$5.79M
2.61
2.61
0.00
-0.00
-0.00
N/A
-128.64
-186.20
2
Margins & Profitability
0.0%
0.0%
0.0%
0.0%
N/A
N/A
0.0%
-6.3%
Returns
-381.5%
-443.1%
-457.8%
-457.8%
-381.5%
Historical Growth (CAGR)
N/A
N/A
N/A
32.9%
32.1%
51.0%
-11.1%
3.1%
-9.9%
Analyst Forecasts
Hold
0
33.4%
N/A
Mar 31, 2027
-$2.50
-95.5%
N/A
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$0.00
N/A
Cash Flow
$-14.43M
$-14.43M
$-15.33M
-$9.29
-$9.29
0.0%
Income Statement
$0
$0
$-16.34M
$-20.33M
$-22.08M
-$104.00
N/A
$-22.08M
1
Add to Watchlist
Select watchlists to add or remove GTBP